Viquidacin - CAS 904302-98-3

Viquidacin (NXL-101) is an oral/intravenous antibiotic that targets Gram-positive bacteria such as MRSA. In 2008, Novexel announced it had discontinued the development of Viquidacin (NXL 101) .

Topoisomerase, Antibacterial, Antibiotic, Others, DNA/RNA Synthesis

Others, Cell Cycle/Checkpoint, Microbiology/Virology, DNA Damage/DNA Repair

904201

C25H29FN2O4S2

504.64

[C@@H](CC[C@H]1[C@@H](C(O)=O)CN(CCSC2=CC=CS2)CC1)(O)C=3C4=C(C=CC(OC)=C4)N=CC3F

-20°C

Ice Packs

Small Compound